Related Experiment Video
Updated: Dec 20, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma
1Department of Neurosurgery, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
Purpose:
Medulloblastoma (MB) is a malignant brain disease in young children. The overall survival of MB patients is disappointing due to absence of effective therapeutics and this could be attributed to the lack of molecular mechanism underlying MB. FHOD3 was an important gene during cardio-genesis and was reported to promote cell migration in cancer. However, its role in MB is not clear to date.
Methods:
RT-qPCR and IHC analysis were used to determine expression of FHOD3. Survival curve was drawn by K-M analysis. FHOD3 was knocked down by RNAi technology. The effects of FHOD3 on medulloblastoma cells were determined by CCK-8 assay, colony formation assay, transwell assay and FACs analysis.
Results:
FHOD3 expression increased by 1.5 fold in tumor tissues compared to the control and IHC analysis further confirmed strong expression of FHOD3 in medulloblastoma tissues. Then higher FHOD3 expression was associated with shorter survival time in MB patients (13.0 months versus 43.8 months). In medulloblastoma cells such as Daoy and D283med, FHOD3 also displayed abundant expression. When FHOD3 was knocked down, the ability of cell proliferation and colony formation was reduced over greatly. The capability of cell migration and invasion was also inhibited significantly. However, cell apoptotic rate increased significantly reversely. Mechanistically, the phosphorylation level of RhoA, ROCK1, and LIMK1 was decreased when FHOD3 was knocked down but increased reversely when FHOD3 was over-expressed in Daoy cells.
Conclusions:
FHOD3 was associated with overall survival time in medulloblastoma patients and was essential to cell proliferation, growth and survival in medulloblastoma and might regulates activation of RhoA/ROCK1/LIMK1 signaling pathway.
Insights
FHOD3 gene expression is elevated in pediatric medulloblastoma, correlating with poorer survival. Inhibiting FHOD3 reduces tumor cell growth, migration, and survival, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Medulloblastoma (MB) is a common pediatric brain cancer with poor survival rates due to limited effective treatments.
- Understanding the molecular mechanisms driving MB is crucial for developing novel therapeutic strategies.
- The gene FHOD3's role in MB pathogenesis remains largely unexplored, despite its known involvement in other cancers and development.
Purpose of the Study:
- To investigate the expression and functional role of FHOD3 in medulloblastoma.
- To determine the association between FHOD3 expression and patient survival outcomes.
- To elucidate the molecular pathways regulated by FHOD3 in medulloblastoma cells.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) and immunohistochemistry (IHC) to assess FHOD3 expression.
- Kaplan-Meier (K-M) analysis to correlate FHOD3 levels with patient survival.
- RNA interference (RNAi) to knockdown FHOD3, followed by cell counting kit-8 (CCK-8), colony formation, Transwell assays, and flow cytometry (FACs) to evaluate cellular functions.
- Western blotting to analyze the phosphorylation status of RhoA, ROCK1, and LIMK1.
Main Results:
- FHOD3 expression was significantly upregulated (1.5-fold) in medulloblastoma tissues compared to controls, confirmed by IHC.
- Higher FHOD3 expression correlated with significantly shorter overall survival in MB patients (13.0 vs. 43.8 months).
- Knockdown of FHOD3 markedly reduced medulloblastoma cell proliferation, colony formation, migration, and invasion, while increasing apoptosis. FHOD3 knockdown also decreased RhoA/ROCK1/LIMK1 pathway activation.
Conclusions:
- FHOD3 is overexpressed in medulloblastoma and is associated with poor patient survival.
- FHOD3 plays a critical role in promoting medulloblastoma cell proliferation, growth, survival, and metastasis.
- FHOD3 may exert its oncogenic functions by regulating the RhoA/ROCK1/LIMK1 signaling pathway, presenting a potential therapeutic target.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
The Ras Gene
Ras is a...
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

